Among genes that are mutated less commonly in bladder cancer, noticeable are likely pathogenic mutations in the nucleotide excision repair helicase ERCC2, observed in three of the 10 cases with TMB above 30 mutations/MB (Table 4). This evidence concerns the gene ERCC2 and urinary bladder cancer.